SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-133829
Filing Date
2020-05-05
Accepted
2020-05-05 17:01:33
Documents
8
Period of Report
2020-05-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d927460d8k.htm 8-K 21346
2 EX-5.1 d927460dex51.htm EX-5.1 12934
3 EX-10.1 d927460dex101.htm EX-10.1 188135
4 EX-99.1 d927460dex991.htm EX-99.1 51474
5 EX-99.2 d927460dex992.htm EX-99.2 13227
6 GRAPHIC g927460g0505082149827.jpg GRAPHIC 3921
7 GRAPHIC g927460g36g40.jpg GRAPHIC 2716
8 GRAPHIC g927460g54t17.jpg GRAPHIC 1765
  Complete submission text file 0001193125-20-133829.txt   300741
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32001 | Film No.: 20849808
SIC: 2836 Biological Products, (No Diagnostic Substances)